Caffeine in Preterm Infants: High-Dose vs. Low-Dose for Apnea, BPD, & Neurodevelopment | NICU скачать в хорошем качестве

Caffeine in Preterm Infants: High-Dose vs. Low-Dose for Apnea, BPD, & Neurodevelopment | NICU

Are we using the optimal dose of caffeine for our premature babies? This in-depth NICU Journal Club hosted by APPNA Pediatrics dives into a critical systematic review and meta-analysis to assess the effectiveness and long-term consequences of high-dose vs. low-dose caffeine for apnea of prematurity (AOP). Join Dr. Simma Pirzada, Dr. Nasar Rashid, and other expert neonatologists as they provide a rigorous, balanced, and sometimes dissenting opinion on the current evidence, clinical practice, and methodological rigor of the literature. Learn how to critically evaluate studies involving Bronchopulmonary Dysplasia (BPD), Patent Ductus Arteriosus (PDA), and neurodevelopmental impairment. Video Highlights & Key Discussion Points 1. Clinical Problem & Physiology 01:39 The Core Clinical Scenario: Loading and maintenance dose debates for extremely pre-term infants. 02:46 What is Apnea of Prematurity (AOP)? Reviewing the latest diagnostic definitions. 03:40 The Physiology of Breathing in Premature Infants: Understanding the role of chemoreceptors and the central nervous system. 06:42 How Caffeine Works: The pharmacological mechanism of methylxanthines and adenosine receptor blockade. 2. Evidence & Methodology 07:59 Evolution of Xanthines: From Theophylline to the landmark Cap Trial (Caffeine for Apnea of Prematurity). 09:36 Study Objective & Methodology: Assessing caffeine's role in reducing apnea and preventing long-term neurodevelopmental impairment. 10:40 Understanding Research Rigor: Explanations of PRISMA flowcharts, Cochrane guidelines, GRADE approach, and database selection. 17:48 Interpreting Forest Plots: Relative Risk, Confidence Intervals, and the critical role of heterogeneity (I 2 ) in meta-analysis. 3. Expert Clinical Debate 23:29 Evidence Summary: Robust effect on BPD and PDA, but uncertainties remain for long-term neurodevelopmental outcomes. 25:28 Changing Practice: Do the meta-analysis findings change real-world caffeine dosing in the NICU (5mg/kg vs. 10mg/kg)? 37:57 High Heterogeneity (I 2 ): Why high heterogeneity invalidates many meta-analysis conclusions and what studies should have been included. 47:56 The Purpose of Research: Why non-positive findings are essential for validating current best practices. 01:09:47 Real-World Challenges: The complexity of cost, sustainability, and practice in resource-limited settings. 🔔 Don't Miss More Critical NICU Discussions! If you are a Neonatologist, Fellow, Resident, or Medical Student interested in evidence-based neonatal care, hit SUBSCRIBE and turn on notifications! #CaffeineInPreterm #ApneaOfPrematurity #NICU #Neonatology #Pediatrics #BPD #Neurodevelopment #HighDoseCaffeine #MedicalEducation #JournalClub #CapTrial #aapna Watch Our Other Videos & Resources 1    / @appnapediatrics   2    / @appnapediatrics   3    • Lectures   4    / @appnapediatrics   5 https://appnapeds.org 6 https://appnapeds.org/links/ 7 https://appnapediatrics.org/ 8   / posts